<VariationArchive VariationID="42568" VariationName="NM_000256.3(MYBPC3):c.1800del (p.Lys600fs)" VariationType="Deletion" Accession="VCV000042568" Version="30" RecordType="classified" NumberOfSubmissions="11" NumberOfSubmitters="11" DateLastUpdated="2024-05-08" DateCreated="2016-05-29" MostRecentSubmission="2024-04-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="51738" VariationID="42568">
      <GeneList>
        <Gene Symbol="MYBPC3" FullName="myosin binding protein C3" GeneID="4607" HGNC_ID="HGNC:7551" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="47331406" stop="47352702" display_start="47331406" display_stop="47352702" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="47352956" stop="47374252" display_start="47352956" display_stop="47374252" Strand="-" />
          </Location>
          <OMIM>600958</OMIM>
          <Haploinsufficiency last_evaluated="2023-01-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MYBPC3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-01-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MYBPC3">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000256.3(MYBPC3):c.1800del (p.Lys600fs)</Name>
      <CanonicalSPDI>NC_000011.10:47341234:TTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="47341235" stop="47341235" display_start="47341235" display_stop="47341235" variantLength="1" positionVCF="47341234" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="47362786" stop="47362786" display_start="47362786" display_stop="47362786" variantLength="1" positionVCF="47362785" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_386" sequenceAccession="LRG_386" change="g.16468del">
            <Expression>LRG_386:g.16468del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_386t1" sequenceAccession="LRG_386t1" change="c.1800del">
            <Expression>LRG_386t1:c.1800del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_386p1" sequenceAccession="LRG_386p1" change="p.Lys600fs">
            <Expression>LRG_386p1:p.Lys600fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.47341237del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.47341237del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.47362788del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.47362788del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007667.1" sequenceAccession="NG_007667" sequenceVersion="1" change="g.16468del">
            <Expression>NG_007667.1:g.16468del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000256.3" sequenceAccession="NM_000256" sequenceVersion="3" change="c.1800delA" MANESelect="true">
            <Expression>NM_000256.3:c.1800delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA011173" DB="ClinGen" />
        <XRef Type="rs" ID="397515926" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000256.3(MYBPC3):c.1800del (p.Lys600fs) AND not provided" Accession="RCV000158353" Version="13">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-26" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000256.3(MYBPC3):c.1800del (p.Lys600fs) AND Cardiovascular phenotype" Accession="RCV000620475" Version="4">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000256.3(MYBPC3):c.1800del (p.Lys600fs) AND Hypertrophic cardiomyopathy 4" Accession="RCV000585656" Version="3">
        <ClassifiedConditionList TraitSetID="2365">
          <ClassifiedCondition DB="MedGen" ID="C1861862">Hypertrophic cardiomyopathy 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-07-16" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000256.3(MYBPC3):c.1800del (p.Lys600fs) AND Hypertrophic cardiomyopathy" Accession="RCV000628851" Version="13">
        <ClassifiedConditionList TraitSetID="17368">
          <ClassifiedCondition DB="MedGen" ID="C0007194">Hypertrophic cardiomyopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-22" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000256.3(MYBPC3):c.1800del (p.Lys600fs) AND Cardiomyopathy" Accession="RCV001798082" Version="3">
        <ClassifiedConditionList TraitSetID="8589">
          <ClassifiedCondition DB="MedGen" ID="C0878544">Cardiomyopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-22" NumberOfSubmissions="11" NumberOfSubmitters="11" DateCreated="2016-05-29" MostRecentSubmission="2024-04-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12707239</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19574547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20433692</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20738943</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22857948</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27532257</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33495597</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8589" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16502" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cardiomyopathy</ElementValue>
                <XRef ID="Cardiomyopathy/1090" DB="Genetic Alliance" />
                <XRef ID="HP:0001638" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0004994" DB="MONDO" />
                <XRef ID="85898001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardiomyopathies</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMYO</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Various modes of inheritance</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11958" />
                <XRef ID="11958" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="20096" />
                <XRef ID="20096" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="AHRQ, 2013">
                <ID Source="BookShelf">NBK248310</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <XRef ID="167848" DB="Orphanet" />
              <XRef ID="C0878544" DB="MedGen" />
              <XRef ID="MONDO:0004994" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001638" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="17368" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="22501" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypertrophic cardiomyopathy</ElementValue>
                <XRef ID="HP:0001639" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005045" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERTROPHIC MYOCARDIOPATHY</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="20518" />
                <XRef ID="20518" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="217569" DB="Orphanet" />
              <XRef ID="C0007194" DB="MedGen" />
              <XRef ID="D002312" DB="MeSH" />
              <XRef ID="MONDO:0005045" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001639" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2365" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1312" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial hypertrophic cardiomyopathy 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypertrophic cardiomyopathy 4</ElementValue>
                <XRef ID="MONDO:0007268" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMH4</ElementValue>
                <XRef Type="MIM" ID="115197" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301725</ID>
                <ID Source="BookShelf">NBK1768</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21267010</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="C1861862" DB="MedGen" />
              <XRef ID="MONDO:0007268" DB="MONDO" />
              <XRef Type="MIM" ID="115197" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="100283" SubmissionDate="2019-03-21" DateLastUpdated="2018-04-09" DateCreated="2013-05-03">
        <ClinVarSubmissionID localKey="37620719|Orphanet:ORPHA217569" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000059083" DateUpdated="2018-04-09" DateCreated="2013-05-03" Type="SCV" Version="5" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000198883" DateChanged="2015-02-23" Version="1" />
        </ReplacedList>
        <Classification DateLastEvaluated="2013-12-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12707239</ID>
          </Citation>
          <Comment>The p.Lys600fs variant in MYBPC3 has been identified by our laboratory in 2 adul ts with HCM. This frameshift variant is predicted to alter the protein?s amino a cid sequence beginning at position 600 and lead to a premature termination codon 2 amino acids downstream. This alteration is then predicted to lead to a trunca ted or absent protein. Heterozygous loss of function of the MYBPC3 gene is an es tablished disease mechanism in HCM patients. In summary, this variant meets crit eria to be classified as pathogenic (http://pcpgm.partners.org/LMM) based upon c onsistency with the established disease causing mechanism.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="4" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="4" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000256.3:EXON 19</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_000256.3:c.1800delA</Name>
            <Name>p.Lys600AsnfsX2</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.47362786delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA217569" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348977</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1438639" SubmissionDate="2023-06-28" DateLastUpdated="2023-07-08" DateCreated="2018-04-14">
        <ClinVarSubmissionID localKey="a44276|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000739948" DateUpdated="2023-07-08" DateCreated="2018-04-14" Type="SCV" Version="5" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12707239</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22857948</ID>
          </Citation>
          <Comment>The c.1800delA pathogenic mutation, located in coding exon 19 of the MYBPC3 gene, results from a deletion of one nucleotide at nucleotide position 1800, causing a translational frameshift with a predicted alternate stop codon (p.K600Nfs*2). This alteration (also known as g.12413delA) was reported in two individuals with hypertrophic cardiomyopathy (Richard P et al. Circulation 2003; 107(17):2227-32; Brito D et al. Rev Port Cardiol 2012; 31(9):577-87). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry General Variant Classification Scheme_2022</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/5hsvndk6/ambry_general_variant_classification_scheme_2022.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000256.3:c.1800delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough061523</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1459105" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="2656945|MedGen:C0007194" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000749758" DateUpdated="2024-02-14" DateCreated="2018-05-28" Type="SCV" Version="8" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19574547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12707239</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20433692</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22857948</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27532257</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys600Asnfs*2) in the MYBPC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYBPC3 are known to be pathogenic (PMID: 19574547). This variant is present in population databases (rs397515926, gnomAD 0.003%). This premature translational stop signal has been observed in individuals with hypertrophic cardiomyopathy (PMID: 12707239, 20433692, 22857948, 27532257). ClinVar contains an entry for this variant (Variation ID: 42568). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.47362786del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0007194" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3855475" SubmissionDate="2021-09-21" DateLastUpdated="2021-10-07" DateCreated="2021-10-07">
        <ClinVarSubmissionID localKey=":Chr.11_47362785_47362786_GT_G|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001969865" DateUpdated="2021-10-07" DateCreated="2021-10-07" Type="SCV" Version="1" SubmitterName="Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center" OrgID="506497" OrganizationCategory="laboratory" OrgAbbreviation="CGDx-EMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="G" referenceAllele="GT" start="47362785" stop="47362786" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10405229</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4988058" SubmissionDate="2022-07-06" DateLastUpdated="2022-07-17" DateCreated="2022-07-17">
        <ClinVarSubmissionID localKey="NM_000256.3:c.1800del" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002548735" DateUpdated="2022-07-17" DateCreated="2022-07-17" Type="SCV" Version="1" SubmitterName="New York Genome Center" OrgID="507558" OrganizationCategory="laboratory" OrgAbbreviation="NYGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12707239</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20433692</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22857948</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27532257</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20738943</ID>
          </Citation>
          <Comment>The inherited c.1800del (p.Lys600AsnfsTer2) variant identified in the MYBPC3 gene is the deletion of a single nucleotide resulting in a frameshift at amino acid 600/1275 (exon 19/35) and is predicted to lead to the premature termination of the protein 2 amino acids downstream. This variant is absent from gnomAD(v3.1.1) suggesting it is not a common benign variant in the populations represented in that database. Loss-of-function variants in MYBPC3 are known to be pathogenic [PMID: 19574547]. The c.1800del (p.Lys600AsnfsTer2) variant is reported in ClinVar as Pathogenic by multiple submitters (VarID: 42568) and has been reported in several individuals affected with hypertrophic cardiomyopathy in the literature [PMID: 12707239, 20433692, 22857948, 27532257, 20738943]. Given this variant is predicted to lead to the premature termination of the protein, its presence in affected individuals in the literature, and absence in population databases, the c.1800del (p.Lys600AsnfsTer2) variant identified in the MYBPC3 gene is reported as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">NYGC Assertion Criteria 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/hhfhf6ms/nygc_assertion_criteria_2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole genome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">yes</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001249" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000717" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000750" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000256.3:c.1800del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="115197" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-NYCKidSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB11741570</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="373937" SubmissionDate="2023-10-04" DateLastUpdated="2023-10-05" DateCreated="2015-02-24">
        <ClinVarSubmissionID localKey="GDXSV:290744" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000208288" DateUpdated="2023-10-05" DateCreated="2015-02-24" Type="SCV" Version="16" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Not observed at significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 12707239, 22857948, 27153395, 27532257, 31589614, 20433692, 20738943)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:41500</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000256.3:c.1800del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_114_20220629054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_171_20230329054202</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_224_20231004054203</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_8_20210622121731</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4007035" SubmissionDate="2024-01-31" DateLastUpdated="2024-02-04" DateCreated="2021-12-29">
        <ClinVarSubmissionID localKey="308007|MedGen:C0878544" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002042143" DateUpdated="2024-02-04" DateCreated="2021-12-29" Type="SCV" Version="2" SubmitterName="CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario" OrgID="1050" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000256.3:c.1800del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0878544" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10844479</SubmissionName>
          <SubmissionName>SUB14193745</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="528709" SubmissionDate="2016-05-06" DateLastUpdated="2016-05-29" DateCreated="2016-05-29">
        <ClinVarSubmissionID localKey="NM_000256.3:c.1800delA|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000280223" DateUpdated="2016-05-29" DateCreated="2016-05-29" Type="SCV" Version="1" SubmitterName="Stanford Center for Inherited Cardiovascular Disease, Stanford University" OrgID="505443" OrganizationCategory="clinic" OrgAbbreviation="SCICD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-04-07">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. p.Lys600AsnfsX2 (p.K600NfsX2, p.K600Nfs, p.Lys600Nfs c.1800delA) in exon 19 of the MYBPC3 gene (NM_000256.3). Given that frameshift variants in this gene are a common cause of HCM and that there is strong case and segregation data, we consider this variant very likely disease causing. The variant has been seen in at least 11 unrelated cases of (not including this patient's family). Richard et al (2003) reported the variant in one of 197 unrelated HCM patients from their French cohort. Most were of European ancestry. They analyzed 9 sarcomere genes. Note they refer to the variant as del A 12413 (I found multiple sources that map this as the same variant as p.Lys600AsnfsX2). No segregation data was provided. Brito et al (2012) observed the variant in one of 77 HCM patients from their Portuguese cohort that underwent analysis of 5 sarcomere genes. They note that segregation analysis was performed but don't give specific data for this variant. I found a Spanish publication that appears to be about preimplantation genetic diagnosis for this variant (Vendrell et al 2009). Rodriguez-Garcia et al (2010) reported the variant in two brothers with HCM from their Spanish cohort of 130 HCM patients. They only analyzed MYBPC3 in this study. The same group included a patient with this variant in a paper on conduction system disease in HCM (Barriales-Villa et al 2010). Unfortunately insufficient case details are available to determine if it is the same patient described in the other report. This group also published a very interesting family with a father and daughter with HCM and this variant and mother and son with hypertrabeculation (Ortiz et al 2009). The son did not carry the variant and presumably inherited hypertrabeculation from his mother. Interestingly, the authors note that they have a total of 8 families with HCM and this variant with 21 carriers and 90% penetrance by 30 years of age (also reported in a poster, Ortiz et al, http://spo.escardio.org/eslides/view.aspx?eevtid=33&amp;fp=3253). There were three different families with three affected members with the variant, including one set of three first cousins. It is in ClinVar with a submission from LMM, classifying it as pathogenic, but not including internal case data (SCV000059083). Michels et al (2011) observed the variant in 1 of 327 unrelated Dutch HCM patients. No individual ancestry or phenotype data was reported. They only analyzed MYBPC3. This is a frame-shifting variant that creates a premature stop codon 2 codons downstream of the variant. The variant is expected to either cause a truncated protein or a completely absent protein due to nonsense-mediated mRNA decay. Many other frameshift and null variants have been identified in MYBPC3 in association with cardiomyopathy (ex. p.Trp792fs, p.Pro794fs, p.Lys1065fs, p.Cys1202fs, p.Pro1208fs, p.Trp1098ter, p.Glu1096ter, p.Cys1124ter, p.Gln1233ter). Furthermore, these types of variants in MYBPC3 are not seen in individuals without cardiomyopathy (Pan et al 2012).. In total the variant has not been seen in ~6800 published controls and individuals from publicly available population datasets. The variant is not listed in the NHLBI Exome Sequencing Project dataset, which currently includes variant calls on ~6500 Caucasian and African American individuals (as of July 15th, 2014). Note that this dataset does not match the patient's ancestry (Hispanic). The variant is listed in dbSNP (rs397515926), however the only submission is from LMMM. The variant was not observed in the following published control samples: 100 healthy adults (Richard et al 2003), 200 controls (Rodriguez-Garcia et al 2010).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="12" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000256.3:c.1800delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>5_6_2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3833633" SubmissionDate="2021-09-30" DateLastUpdated="2021-10-02" DateCreated="2021-10-02">
        <ClinVarSubmissionID localKey=":Chr.11_47362785_47362786_GT_G|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001955754" DateUpdated="2021-10-02" DateCreated="2021-10-02" Type="SCV" Version="1" SubmitterName="Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+" OrgID="505925" OrganizationCategory="laboratory" OrgAbbreviation="Radboudumc_MUMC+" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="G" referenceAllele="GT" start="47362785" stop="47362786" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10449206</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1359156" SubmissionDate="2017-11-15" DateLastUpdated="2022-12-11" DateCreated="2018-03-04">
        <ClinVarSubmissionID localKey="13_October 2017|OMIM:115197" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000693459" DateUpdated="2022-12-11" DateCreated="2018-03-04" Type="SCV" Version="2" SubmitterName="Center of Genomic medicine, Geneva, University Hospital of Geneva" OrgID="505593" OrganizationCategory="laboratory" OrgAbbreviation="GenMed_GVA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-08-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">50</Age>
              <Age Type="maximum" age_unit="years">59</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.(Lys600Asnfs*2)</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000256.3:c.1800del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="115197" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Genome_Clinic_of_Geneva_November2017</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9008800" SubmissionDate="2024-04-16" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="604591|MONDO:0005045" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004816475" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="All of Us Research Program, National Institutes of Health" OrgID="509529" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12707239</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20433692</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20738943</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22857948</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27532257</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33495597</ID>
          </Citation>
          <Comment>This variant deletes 1 nucleotide in exon 19 of the Ig-like domain C4 of the MYBPC3 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has been reported in individuals affected with hypertrophic cardiomyopathy (PMID: 12707239, 20433692, 20738943, 22857948, 27532257, 33495597). This variant has been identified in 1/203524 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of MYBPC3 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>108544</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.47362786del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0005045" />
          </Trait>
        </TraitSet>
        <Comment>This study involves interpretation of variants in research participants for the purpose of population health screening. Participant phenotype was not available at the time of variant classification. Additional details can be found in publication PMID: 35346344, PMCID: PMC8962531</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB14382316</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3833633" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="100283" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA217569" MappingRef="Orphanet">
        <MedGen CUI="C0007194" Name="Hypertrophic cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4988058" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000750" MappingRef="HP">
        <MedGen CUI="C0454644" Name="Delayed speech and language development" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4988058" TraitType="Disease" MappingType="XRef" MappingValue="115197" MappingRef="OMIM">
        <MedGen CUI="C1861862" Name="Hypertrophic cardiomyopathy 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4988058" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000717" MappingRef="HP">
        <MedGen CUI="C0004352" Name="Autism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1438639" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1359156" TraitType="Disease" MappingType="XRef" MappingValue="115197" MappingRef="OMIM">
        <MedGen CUI="C1861862" Name="Hypertrophic cardiomyopathy 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9008800" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0005045" MappingRef="MONDO">
        <MedGen CUI="C0007194" Name="Hypertrophic cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="373937" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4988058" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001249" MappingRef="HP">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1459105" TraitType="Disease" MappingType="XRef" MappingValue="C0007194" MappingRef="MedGen">
        <MedGen CUI="C0007194" Name="Hypertrophic cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4007035" TraitType="Disease" MappingType="XRef" MappingValue="C0878544" MappingRef="MedGen">
        <MedGen CUI="C0878544" Name="Cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="528709" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3855475" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>